# Shoe Station Group Inc: overview

SHOE · Nasdaq · CIK 895447 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/shoe.md) · [Financials](/companies/shoe/financials.md) · [Filings](/companies/shoe/filings.md) · [Insiders](/companies/shoe/insiders.md)

Latest reported revenue: [$284.3m](/filings/0001193125-26-387855.md) for Q2 FY2026, three months to 2026-08-01, from the 10-Q filed Sep 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-387855).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [307](/filings/0001193125-25-308714.md) | [263 d](/filings/0001193125-26-126279.md) | [278](/filings/0001193125-26-258362.md) | [306](/filings/0001193125-26-387855.md) | [297](/filings/0001193125-25-308714.md) | [254 d](/filings/0001193125-26-126279.md) | [271](/filings/0001193125-26-258362.md) | [284](/filings/0001193125-26-387855.md) |
| Gross margin | % | [36.0%](/filings/0001193125-25-308714.md) | [34.9% d](/filings/0001193125-26-126279.md) | [34.5%](/filings/0001193125-26-258362.md) | [38.8%](/filings/0001193125-26-387855.md) | [37.6%](/filings/0001193125-25-308714.md) | [34.9% d](/filings/0001193125-26-126279.md) | [33.3%](/filings/0001193125-26-258362.md) | [31.9%](/filings/0001193125-26-387855.md) |
| Operating margin | % | [8.0%](/filings/0001193125-25-308714.md) | [5.3% d](/filings/0001193125-26-126279.md) | [4.3%](/filings/0001193125-26-258362.md) | [8.2%](/filings/0001193125-26-387855.md) | [6.3%](/filings/0001193125-25-308714.md) | [4.3% d](/filings/0001193125-26-126279.md) | [(2.2%)](/filings/0001193125-26-258362.md) | [2.7%](/filings/0001193125-26-387855.md) |
| Net margin | % | [6.3%](/filings/0001193125-25-308714.md) | [5.6% d](/filings/0001193125-26-126279.md) | [3.4%](/filings/0001193125-26-258362.md) | [6.3%](/filings/0001193125-26-387855.md) | [4.9%](/filings/0001193125-25-308714.md) | [3.6% d](/filings/0001193125-26-126279.md) | [(2.1%)](/filings/0001193125-26-258362.md) | [2.2%](/filings/0001193125-26-387855.md) |
| Diluted EPS | $ per share | [0.70](/filings/0001193125-25-308714.md) | not reported | [0.34](/filings/0001193125-26-258362.md) | [0.70](/filings/0001193125-26-387855.md) | [0.53](/filings/0001193125-25-308714.md) | not reported | [(0.21)](/filings/0001193125-26-258362.md) | [0.23](/filings/0001193125-26-387855.md) |
| Free cash flow | $m | [8.3 d](/filings/0001193125-25-308714.md) | [36.2 d](/filings/0001193125-26-126279.md) | [(23.0)](/filings/0001193125-26-258362.md) | [2.2 d](/filings/0001193125-26-387855.md) | [19.7 d](/filings/0001193125-25-308714.md) | [27.7 d](/filings/0001193125-26-126279.md) | [12.6](/filings/0001193125-26-258362.md) | [6.5 d](/filings/0001193125-26-387855.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-29) | FY2022 (2023-01-28) | FY2023 (2024-02-03) | FY2024 (2025-02-01) | FY2025 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,330](/filings/0000950170-24-035337.md) | [1,262](/filings/0000950170-25-043195.md) | [1,176](/filings/0001193125-26-126279.md) | [1,203](/filings/0001193125-26-126279.md) | [1,135](/filings/0001193125-26-126279.md) |
| Gross margin | % | [39.6%](/filings/0000950170-24-035337.md) | [37.1%](/filings/0000950170-25-043195.md) | [35.8%](/filings/0001193125-26-126279.md) | [35.6%](/filings/0001193125-26-126279.md) | [36.6%](/filings/0001193125-26-126279.md) |
| Operating margin | % | [15.6%](/filings/0000950170-24-035337.md) | [11.6%](/filings/0000950170-25-043195.md) | [8.0%](/filings/0001193125-26-126279.md) | [7.6%](/filings/0001193125-26-126279.md) | [5.9%](/filings/0001193125-26-126279.md) |
| Net margin | % | [11.6%](/filings/0000950170-24-035337.md) | [8.7%](/filings/0000950170-25-043195.md) | [6.2%](/filings/0001193125-26-126279.md) | [6.1%](/filings/0001193125-26-126279.md) | [4.6%](/filings/0001193125-26-126279.md) |
| Diluted EPS | $ per share | [5.42](/filings/0000950170-24-035337.md) | [3.96](/filings/0000950170-25-043195.md) | [2.68](/filings/0001193125-26-126279.md) | [2.68](/filings/0001193125-26-126279.md) | [1.90](/filings/0001193125-26-126279.md) |
| Free cash flow | $m | [117](/filings/0000950170-24-035337.md) | [(26.9)](/filings/0000950170-25-043195.md) | [66.5](/filings/0001193125-26-126279.md) | [69.5](/filings/0001193125-26-126279.md) | [26.6](/filings/0001193125-26-126279.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/shoe/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $29.0m | 1,955,955 |  | Added +197,541 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $22.6m | 1,525,350 |  | Reduced −125,982 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $11.7m | 788,626 |  | Added +15,288 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $11.3m | 763,229 |  | Added +245,283 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $10.8m | 730,310 |  | Added +62,961 |
| [NEW SOUTH CAPITAL MANAGEMENT INC](/funds/1044797.md) | 2026-06-30 | $10.6m | 717,149 |  | Reduced −24,164 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $9.5m | 642,119 |  | Reduced −469,531 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $9.4m | 635,922 |  | Added +88,337 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $8.2m | 549,815 |  | Reduced −3,305 |
| [JACOBS LEVY EQUITY MANAGEMENT, INC](/funds/884414.md) | 2026-06-30 | $7.4m | 497,734 |  | Added +395,548 |

## Recent filings

[All 829 filings](/companies/shoe/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 20:47 ET | [8-K](/filings/0001193125-26-422982.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-422982 |
| 2026-09-10 | 20:05 ET | [10-Q](/filings/0001193125-26-387855.md) | Quarterly report, period 2026-08-01 | 0001193125-26-387855 |
| 2026-09-10 | 10:15 ET | [8-K](/filings/0001193125-26-387134.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-387134 |
| 2026-06-11 | 10:15 ET | [8-K](/filings/0001193125-26-266625.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-266625 |
| 2026-06-05 | 11:00 ET | [10-Q](/filings/0001193125-26-258362.md) | Quarterly report, period 2026-05-02 | 0001193125-26-258362 |
| 2026-05-21 | 10:15 ET | [8-K](/filings/0001193125-26-233317.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-233317 |
| 2026-04-29 | 20:05 ET | [DEF 14A](/filings/0001193125-26-191497.md) | Proxy statement, period 2026-06-10 | 0001193125-26-191497 |
| 2026-03-26 | 20:15 ET | [10-K](/filings/0001193125-26-126279.md) | Annual report, period 2026-01-31 | 0001193125-26-126279 |
| 2026-03-26 | 10:20 ET | [8-K](/filings/0001193125-26-125001.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-125001 |
| 2026-03-09 | 20:05 ET | [8-K](/filings/0001193125-26-098464.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-098464 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001193125-26-126279.md), filed Mar 26, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 895447
- Tickers: SHOE
- Exchange: Nasdaq
- SIC code: 5661 Retail-Shoe Stores
- State of incorporation: IN
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.